The 2025 China-Hungary Anti-Cancer Summit will take place on September 17th, 2025, from 15:00 to 17:00 Beijing Standard Time (9:00 to 11:00 Budapest Standard Time).
This event will be hosted via Zoom and conducted in English with simultaneous Chinese translation. Organized by the China Anti-Cancer Association (CACA), the Hungarian League Against Cancer (HLAC), and the World Association for Integrative Oncology (WAIO), the summit aims to foster collaboration and share expertise between China and Hungary in the field of cancer management.
Participants will have the opportunity to engage with leading experts presenting on vital topics including holistic integrative management of cancer, breast cancer screening programs, AI and multidisciplinary treatment approaches, epidemiology, and cancer care challenges.
Opening Remarks:
Ying Wang: Vice President of China Anti-Cancer Association; Secretary General of Asian Oncology Society; Secretary General of World Association for Integrative Oncology
Moderators: Balázs Rozványi (President, Hungarian League Against Cancer; Board member, Hungarian Alliance of Patients’ Organisations; Board member, WAIO)
Keynote Presentation
Binghe Xu: Deputy Director, Academic Committee in Chinese Academy of Medical Sciences; Tenured Professor, Peking Union Medical College (PUMC); Executive Member, China Anti-Cancer Association
Ákos Nagy: Hungarian League Against Cancer
Speakers
- Daiming Fan, China Anti-Cancer Association, Asian Oncology Society, WAIO
Topic: Development of holistic integrative management of cancer in China - Balázs Rozványi, Hungarian League Against Cancer, Hungarian Alliance of Patients’ Organisations, WAIO
Topic: Lessons learned from the Hungarian breast cancer screening program - Zhe’an Lin, Taiwan Science and Technology Association, Taiwan Medical Science Research Institute
Topic: AI-MDT – Cutting-edge thinking in cancer treatment - Tamás Mátrai, National Institute of Oncology, Tritonlife Hospital
Topic: Breast cancer epidemiology and care in Hungary: Progress, challenges, collaboration - Kexin Chen, Tianjin Key Laboratory of Molecular Cancer Epidemiology, CACA Cancer Epidemiology Committee
Topic: Breast cancer screening in China: Current evidence and future challenge
To attend, you can scan the QR code or visit the official event website.
